Combination of protein tyrosine kinase inhibitor AG1024 with paclitaxel enhances cell program death in BCR-ABL-mediated resistance of K562 cell line
碩士 === 國立陽明大學 === 醫學生物技術研究所 === 93 === Chronic myelogenous leukaemia (CML) is a clonal malignancy of the pluripotent haematopoietic stem cell, characterised by an uncontrolled proliferation and expansion of myeloid progenitors expressing a fusion oncogene, BCR-ABL, the molecular counterpart of the P...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2005
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/30227831001776366712 |